Accessibility Information

Users of assistive technologies such as screen readers should use the following link to activate Accessibility Mode before continuing: Learn more and Activate accessibility mode.

Q -- Cell-based Monovalent Pandemic Influenza Vaccine

Solicitation Number: 2004-N-011002
Agency: Department of Health and Human Services
Office: Centers for Disease Control and Prevention
Location: Procurement and Grants Office (Atlanta)
  • Print
:
2004-N-011002
:
Award
:
March 31, 2005
:
200-2005-11758
:
97,132,833.00
:
Sanofi Pasteur, SA2, Avenue Pont Pasteur
Lyon, France 69007
:
Added: December 23, 2003 Modified: April 5, 2005Track Changes
No Description Provided
Please consult the list of document viewers if you cannot open a file.

Solicitation 1

Sensitive/Secure Package:
no
Type:
Solicitation
Posted Date:
February 18, 2004
20040218153803.zip (656.74 Kb)
Description: All Files

Amendment 1

Sensitive/Secure Package:
no
Type:
Mod/Amendment
Posted Date:
February 25, 2004
Description: All Files

Amendment 2

Sensitive/Secure Package:
no
Type:
Mod/Amendment
Posted Date:
April 1, 2004
20040401161200.zip (160.81 Kb)
Description: All Files

Amendment 3

Sensitive/Secure Package:
no
Type:
Mod/Amendment
Posted Date:
June 24, 2004
Description: All Files
:
Department of Health and Human Services, Center for Disease Control and Prevention, Procurement and Grants Office (Atlanta), 2920 Brandywine Road, Room 3000, Atlanta, GA, 30341-4146
:
Peter Penny, Contract Specialist, Phone 770-488-1115, Fax 770-488-2777, Email pmp7@cdc.gov - Lorenzo Falgiano, Contract Specialist, Phone (770) 488-2629, Fax (770) 488-2670, Email ljf5@cdc.gov